Contemporary management of peripheral arterial disease: III. Endovascular and surgical management

Cleveland Clinic Journal of Medicine

Volumn 73, Issue SUPPL.4, 2006, Pages 45-51

  Almahameed, Amjad ^a   Bhatt, Deepak L ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL TRANSPLANTATION; FIBRINOLYTIC THERAPY; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; REVIEW; STENT;

ANGIOPLASTY, BALLOON; BLOOD VESSEL PROSTHESIS IMPLANTATION; HUMANS; PERIPHERAL VASCULAR DISEASES; STENTS; THROMBOLYTIC THERAPY;

EID: 34247574684     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.73.Suppl_4.S45     Document Type: Review

References (33)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31(1 Pt 2):S1-S296.
2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation 2006; 113:e463-e654.
3. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a new technique and a preliminary report of its applicaton. Circulation 1964; 30:654-670.
4. Feinglass J, Brown JL, LoSasso A, et al. Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996. Am J Public Health 1999; 89:1222-1227.
5. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med 1991; 325:556-562.
6. Krajcer Z, Howell MH. Update on endovascular treatment of peripheral vascular disease: new tools, techniques, and indications. Tex Heart Inst J 2000; 27:369-385.
7. Murray JG, Apthorp LA, Wilkins RA. Long-segment (= 10 cm) femoropopliteal angioplasty: improved technical success and longterm patency. Radiology 1995; 195:158-162.
8. Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in ptients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology 1994; 191:727-733.
9. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991; 83:I70-I80.
10. Ring EJ, Freiman DB, McLean GK, Schwarz W. Percutaneous recanalization of common iliac artery occlusions: an unacceptable complication rate? AJR Am J Roentgenol 1982; 139:587-589.
11. Colapinto RF, Stronell RD, Johnston WK. Transluminal angioplasty of complete iliac obstructions. AJR Am J Roentgenol 1986; 146:859-862.
12. Schurmann K, Mahnken A, Meyer J, et al. Long-term results 10 years after iliac arterial stent placement. Radiology 2002; 224:731-738.
13. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204:87-96.
14. Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass? Analysis of 70 consecutive cases with longterm follow-up. J Vasc Surg 1996; 24:363-369; discussion 369-370.
15. White CJ. Non-surgical treatment of patients with peripheral vascular disease. Br Med Bull 2001; 59:173-192.
16. Martin EC. Transcatheter therapies in peripheral and noncoronary vascular disease. Introduction. Circulation 1991; 83(2 Suppl):I1-I5.
17. Greenberg D, Rosenfield K, Garcia LA, et al. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). J Vasc Interv Radiol 2004; 15:1065-1069.
18. Ouriel K, Shortell CK, DeWeese JA, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatmentof acute peripheral arterial ischemia. J Vasc Surg 1994; 19:1021-1030.
19. The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lowerextremity. The STILE trial. Ann Surg 1994; 220:251-266; discussion 266-268.
20. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterialocclusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998; 338:1105-1111.
21. Berridge DC, Makin GS, Hopkinson BR. Local low dose intraarterial thrombolytic therapy: the risk of stroke or major haemorrhage. Br J Surg 1989; 76:1230-1233.
22. Voorhees AB Jr, Jaretzki A III, Blakemore AH. The use of tubes constructed from vinyon "N" cloth in bridging arterial defects. Ann Surg 1952; 135:332-336.
23. Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986; 3:104-114.
24. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990; 11:193-205; discussion 205-206.
25. Belkin M, Knox J, Donaldson MC, et al. Infrainguinal arterial reconstruction with nonreversed greater saphenous vein. J Vasc Surg 1996; 24:957-962.
26. Ouriel K. Peripheral arterial disease. Lancet 2001; 358:1257-1264.
27. Albers M, Romiti M, Brochado-Neto FC, Pereira CA. Metaanalysis of alternate autologous vein bypass grafts to infrapopliteal arteries. J Vasc Surg 2005; 42:449-455.
28. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
29. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341:1789-1794.
30. Brady AR, Gibbs JS, Greenhalgh RM, et al. Perioperative betablockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005; 41:602-609.
31. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107:1848-1851.
32. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomizedtrial. J Vasc Surg 2004; 39:967-975; discussion 975-976.
33. Abbruzzese TA, Havens J, Belkin M, et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 2004; 39:1178-1185.